Reported Reactions

Devices › Set, administration, intravascular

Device brand name · Subcutaneous infusion set

Accu-Chek Flexlink Plus Infusion Set: medical device reports filed with FDA

864 reports name it, 2010–2025. Manufacturer given most often on reports: Roche Diabetes Care. Product code FPA.

864
device reports naming the brand
0% of all MAUDE reports · about 55 a year
0
reports, 12 months to August 2026
47 in the 12 months before
90.9%
classified as malfunction
79.3% across the product code
0.1%
classified as death, as reported
1 reports · not verified by FDA

FDA's MAUDE database holds 864 reports that name the brand "Accu-Chek Flexlink Plus Infusion Set" (subcutaneous infusion set), received between September 2010 and May 2025; the manufacturer given most often on reports is Roche Diabetes Care. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, against 47 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (90.9%), injury (8.9%) and death (0.1%); across all set, administration, intravascular reports (product code FPA) death is recorded in 0.2% and malfunction in 79.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are leak/splash (41.7%), nonstandard device (19.8%) and fluid/blood leak (17.2%). The patient problems coded most often are hyperglycemia, elevated ketones/ diabetic ketoacidosis and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01836Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 4Jun 2024: 2Jul 2024: 27Aug 2024: 3Sep 2024: 0Oct 2024: 6Nov 2024: 4Dec 2024: 12025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 36Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01182362010: 2020102011: 23620112015: 7120152016: 13420162017: 16920172018: 7620182019: 5320192020: 2220202024: 4720242025: 362025

Event type and report source

Event type, as classified on the report

Death0.1%1
Injury8.9%77
Malfunction90.9%785
Other0.1%1
Not given0%0

Who filed the report

Manufacturer report100%864
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 349,387 reports carrying product code FPA. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Leak/splashthe device leaked36041.7%11.2%
Nonstandard device17119.8%0.1%
Fluid/blood leak14917.2%13.5%
Bent14616.9%0.4%
High test results13515.6%0.1%
Failure to adhere or bond728.3%0.4%
Kinkedthe tube or line kinked354.1%0.2%
Loss of or failure to bond283.2%14%
Detachment of device or device componentpart of the device came off232.7%3.9%
Disconnection232.7%1.8%
Difficult to insertthe device was hard to insert212.4%0.1%
Material separation212.4%1.8%
Defective devicethe device was defective161.9%0.2%
Device emits odor161.9%0%
Insufficient device problem information141.6%0.3%
Device dislodged or dislocated101.2%0.1%
Device displays incorrect message101.2%0.8%
Occlusion within devicethe device blocked101.2%0.6%
Difficult to removethe device was hard to remove70.8%0.1%
Breakthe device broke60.7%2.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Hyperglycemiahigh blood sugar38244.2%
Elevated ketones/ diabetic ketoacidosis182.1%
Painpain, site not specified101.2%
Aneurysm60.7%
Hypoglycemialow blood sugar50.6%
Swellingswelling40.5%
Foreign body in patientpart of a device left in the patient30.3%
Skin irritationirritated skin30.3%
Abscessa collection of pus20.2%
Burning sensationa burning feeling20.2%
Dehydrationdehydration20.2%
Erythemaskin redness20.2%
Headachehead pain20.2%
Purulent discharge20.2%
Underdoseless than the intended dose20.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAccu-Chek Flexlink Plus Infusion SetProduct code FPAAll MAUDE reports
Reports864349,38726,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports129
Classified as injury8.9%20%36.2%
Classified as malfunction90.9%79.3%62.3%
Filed by the manufacturer100%96.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FPA

BrandReportsLatest 12 monthsClassified as death
Inset Guard47,27647,2220.1%
Inset26,40525,6560%
Quick Set23,35123,0280.4%
Autosoft Xc20,328490%
Autosoft 9012,143150%
Access14,16000%
Other Accessories10,42910,4251.7%
Alaris Pump Module Administration Set8,49200.2%
Contact Detach6,4736,1570.1%
Inset 303,5283,4610%
Cadd10,81190.1%
Minimed Quick-Set3,10160%
Cleo 90 Infusion Set3,006230%
Trusteel2,886140%
Autosoft 302,37410%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Accu-Chek Flexlink Plus Infusion Set reports

How many FDA reports name Accu-Chek Flexlink Plus Infusion Set?

864 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (90.9%), injury (8.9%) and death (0.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

leak/splash (41.7%), nonstandard device (19.8%), fluid/blood leak (17.2%), bent (16.9%) and high test results (15.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Accu-Chek Flexlink Plus Infusion Set was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.